Abstract
Although intravesical therapy with bacillus Calmette-Guérin (BCG) has proven its efficiency in the treatment of early-stage bladder cancer, infectious complications can occur and mycotic aneurysms represent a rare but life-threatening complication. Here, we report the case of an aortic graft infection in a patient with abdominal aortic aneurysm who received BCG instillations for the treatment of bladder cancer. Based on the current knowledge on this rare vascular complication, we discuss factors that may have contributed to its occurrence and review issues to optimize its management and early detection.
Keywords:
BCG; abdominal aortic aneurysm; bacillus Calmette-Guérin; graft infection; mycotic aneurysm.
MeSH terms
-
Administration, Intravesical
-
Aged
-
Aneurysm, Infected / diagnostic imaging
-
Aneurysm, Infected / microbiology
-
Aneurysm, Infected / surgery*
-
Antitubercular Agents / therapeutic use
-
Aortic Aneurysm, Abdominal / diagnostic imaging
-
Aortic Aneurysm, Abdominal / microbiology
-
Aortic Aneurysm, Abdominal / surgery*
-
Aortography / methods
-
BCG Vaccine / administration & dosage
-
BCG Vaccine / adverse effects*
-
Blood Vessel Prosthesis / adverse effects*
-
Blood Vessel Prosthesis Implantation / adverse effects*
-
Blood Vessel Prosthesis Implantation / instrumentation
-
Computed Tomography Angiography
-
Humans
-
Male
-
Prosthesis-Related Infections / diagnostic imaging
-
Prosthesis-Related Infections / drug therapy
-
Prosthesis-Related Infections / microbiology*
-
Treatment Outcome
-
Urinary Bladder Neoplasms / therapy*
Substances
-
Antitubercular Agents
-
BCG Vaccine